Short Information | Emergent Biosolutions Inc. (NYSE:EBS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 178,841 |
Total Actual Volume | 20,750,455 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 8,942 |
Average Short Percentage | 0.86% |
Is there a EBS Short Squeeze or Breakout about to happen?
See the EBS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-19-2024 | $1.84 | $2.04 | $2.06 | $1.84 | 924,755 | 11,244 | 1.22% |
04-18-2024 | $1.9 | $1.86 | $1.99 | $1.8201 | 1,061,154 | 7,724 | 0.73% |
04-17-2024 | $1.96 | $1.9 | $1.9871 | $1.89 | 692,033 | 6,706 | 0.97% |
04-16-2024 | $1.96 | $1.95 | $2.04 | $1.91 | 859,265 | 4,009 | 0.47% |
04-15-2024 | $2.06 | $1.98 | $2.13 | $1.95 | 1,248,734 | 5,375 | 0.43% |
04-12-2024 | $2.2 | $2.06 | $2.2 | $2 | 1,008,941 | 16,937 | 1.68% |
04-11-2024 | $2.24 | $2.19 | $2.28 | $2.17 | 959,852 | 4,256 | 0.44% |
04-10-2024 | $2.27 | $2.23 | $2.28 | $2.2 | 888,008 | 2,210 | 0.25% |
04-09-2024 | $2.32 | $2.31 | $2.38 | $2.245 | 803,018 | 2,821 | 0.35% |
04-08-2024 | $2.32 | $2.32 | $2.34 | $2.25 | 841,232 | 5,391 | 0.64% |
04-05-2024 | $2.27 | $2.29 | $2.41 | $2.195 | 1,117,712 | 3,276 | 0.29% |
04-04-2024 | $2.3 | $2.27 | $2.375 | $2.21 | 1,022,988 | 3,229 | 0.32% |
04-03-2024 | $2.12 | $2.26 | $2.3699 | $2.105 | 1,340,822 | 1,957 | 0.15% |
04-02-2024 | $2.26 | $2.16 | $2.28 | $2.12 | 1,374,124 | 15,892 | 1.16% |
04-01-2024 | $2.55 | $2.3 | $2.6056 | $2.28 | 1,111,434 | 13,814 | 1.24% |
03-28-2024 | $2.61 | $2.53 | $2.718 | $2.45 | 1,089,156 | 14,376 | 1.32% |
03-27-2024 | $2.47 | $2.59 | $2.64 | $2.465 | 1,065,995 | 1,116 | 0.1% |
03-26-2024 | $2.56 | $2.44 | $2.6 | $2.43 | 1,170,592 | 11,227 | 0.96% |
03-25-2024 | $2.43 | $2.54 | $2.635 | $2.43 | 949,444 | 21,690 | 2.28% |
03-22-2024 | $2.47 | $2.41 | $2.51 | $2.4 | 1,221,196 | 25,591 | 2.1% |
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
WARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolo...
As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN ® Nasal Spray and build on its longstanding efforts with public interest entities across the country Hundreds of thousands...
GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has listed “No Action Indicated” or NAI status classification for the company's Baltimore Bayview manufacturing facility. Base...